N2 Biomedical was awarded two patents earlier this year by the United States Patents Office: one for the company's proprietary Dual Action NanoCoating (pictured) and another for its Mesoporous Surface for Enhanced Bone Integration process.
The company's Dual Action Nano-Coating process deposits biocompatible and antibacterial properties into a single film less than 10 microns thick, offering infection prevention and promoting osseointegration for medical and dental implants, according to the company. The nano-engineered surface aims to reduce bacterial colonization and biofilm formation, allowing osteoblasts to win the race to the surface, it reported in a news release.
“I am proud of our senior scientist Jason Burns and the entire N2 engineering team for continuing to advance the surface science needed to address these important healthcare challenges,” president and CEO of N2 Biomedical Randall Sword stated in the release. “The work and lab results to-date are promising, and we look forward to bringing this important technology to the market quickly.”
N2 Biomedical's process for creating Mesoporous Surface for Enhanced Bone Integration engineers multiple levels of texture on a medical device surface, including the macro, micro, and meso, or sub-nanoscale levels.
“This low-temperature process can be applied to a wide variety of metal, ceramic, and polymer implants,” Sword stated. “It is particularly well-suited to polyether ether ketone (PEEK) spinal interbodies, interference screws, and suture anchors. The mesoporus surface structure improves the ossointegration of PEEK implants yet maintains all material property advantages of PEEK over titanium implants, which include mechanical similarity to bone, radio translucency and ease of surgical revisions.”